Dolby Laboratories, Inc.: Dolby Laboratories Reports First Quarter 2025 Financial Results
Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal ...
Dolby Laboratories, Inc. Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next
Dolby Laboratories, Inc. ( NYSE:DLB ) investors will be delighted, with the company turning in some strong numbers ...
CervoMed provides update on neflamapimod DLB program
CervoMed (CRVO) provided an update on its neflamapimod development program in dementia with Lewy bodies, DLB, as part of an oral presentation ...
CervoMed Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia Conference
Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from participants who have received capsules from a more recently ma ...
Cognition announces Phase 2 ‘SHIMMER’ study to be presented at ILBDC
Cognition Therapeutics (CGTX) announced that JamesGalvin, MD, MPH will present topline results from the ‘SHIMMER’ study of zervimesine in ...